HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy.

Abstract
The photodynamic activity of a carrier-sensitizer system consisting of heterotopic colloidal nanoparticles (diameter 100-1000 nm) of a cationic amphiphilic cyclodextrin, heptakis(2-omega-amino-O-oligo(ethylene oxide)-6-hexylthio)-beta-CD (SC6CDNH2) encapsulating the anionic 5,10,15,20-tetrakis(4-sulfonatophenyl)-21H,23H-porphyrin (TPPS) is investigated by an interdisciplinary approach involving the combination of time-resolved absorption and emission techniques with in vitro studies on cultured tumor cells. In a range of TPPS:SC6CDNH2 molar ratios between 1:10 and 1:50 these nanoparticles preserve the photodynamic properties of the entrapped photoactive agent. In fact, the triplet state of TPPS is efficiently populated, very long-lived and, as a consequence, able to produce singlet oxygen (the essential species for the photodynamic action) with quantum yield comparable to the free TPPS. Photodynamic efficacy of the carrier/sensitizer system is proven by in vitro studies on tumor Hela cells treated with TPPS:SC6CDNH2 at different molar ratio, showing significant cells death upon illumination with visible light.
AuthorsSalvatore Sortino, Antonino Mazzaglia, Luigi Monsù Scolaro, Francesca Marino Merlo, Vincenza Valveri, Maria Teresa Sciortino
JournalBiomaterials (Biomaterials) Vol. 27 Issue 23 Pg. 4256-65 (Aug 2006) ISSN: 0142-9612 [Print] Netherlands
PMID16620960 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclodextrins
  • Porphyrins
  • Surface-Active Agents
Topics
  • Cyclodextrins
  • Drug Delivery Systems
  • HeLa Cells
  • Humans
  • Nanostructures
  • Neoplasms (drug therapy)
  • Photochemotherapy
  • Porphyrins
  • Surface-Active Agents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: